Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
45,650
Sort by:
HIV Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Mode (Self-test), By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days HIV Diagnostics Market Growth & Trends The global HIV diagnostics market size is estimated t%li%reach USD 1.55 billion by 2030, exp...
January 2025
180 pages
Fecal Occult Testing Market Report by Test Type (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test), End User (Hospitals, Clinical Diagnostic Laboratories, Physician Office Laboratories), and Region 2025-2033
US$ 2,999.00
The global fecal occult testing market size reached USD 1,426.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,142.2 Million by 2033, exhibiting a growth rate (CAGR) o...
January 2025
127 pages
UAE Clinical Microbiology Market By Product (Laboratory Instruments, Automated Culture System, Reagents), By Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Other Diseases), By Region, Competition, Forecast and Opportunities, 2020-2030F
US$ 3,500.00
UAE Clinical Microbiology Market was valued at USD 28.75 Million in 2024 and is expected to reach USD 42.15 Million with a CAGR of 6.54% through 2030. The UAE Clinical Microbiology Market is experienc...
January 2025
82 pages
